Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2020 ∙ Avni-Singer, L. R. Yakely, A. Sheth, S. S. Shapiro, E. D. Niccolai, L. M. Oliveira, C. R.
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
Americas United States of America Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Rating:
Not applicable
2020 ∙ Beyer, W. E. P. Palache, A. M. Reperant, L. A. Boulfich, M. Osterhaus, Adme
Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines
All age groups Influenza Efficacy/effectiveness Administration
Rating:
Not applicable
2020 ∙ Choe, Y. J. Blatt, D. B. Lee, H. J. Choi, E. H.
Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis
Newborn Pneumococcal disease Coverage
Rating:
Not applicable
2020 ∙ Bangura, J. B. Xiao, S. Qiu, D. Ouyang, F. Chen, L.
Barriers to childhood immunization in sub-Saharan Africa: A systematic review
Africa All age groups Parents/caregivers Coverage Acceptance
Rating:
Not applicable
2020 ∙ Guzman-Holst, A. DeAntonio, R. Prado-Cohrs, D. Juliao, P.
Barriers to vaccination in Latin America: A systematic literature review
Americas All age groups Healthcare workers Pregnant women Acceptance Coverage
Rating:
Not applicable
2020 ∙ Arlegui, H. Bollaerts, K. Salvo, F. Bauchau, V. Nachbaur, G. Begaud, B. Praet, N.
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
All age groups Rotavirus Influenza Dengue Modeling
Rating:
Not applicable
2020 ∙ Jorgensen, L. Gotzsche, P. C. Jefferson, T.
Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
Adolescents Adults Older adults Human papillomavirus (HPV) Efficacy/effectiveness Safety
Rating:
Critically low
2020 ∙ Jorgensen, L. Gotzsche, P. C. Jefferson, T.
Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
Adolescents Adults Older adults Human papillomavirus (HPV) Efficacy/effectiveness Safety Administration
Rating:
Critically low
2020 ∙ Truelove, S. A. Keegan, L. T. Moss, W. J. Chaisson, L. H. Macher, E. Azman, A. S. Lessler, J.
Clinical and epidemiological aspects of diphtheria: A systematic review and pooled analysis
All age groups Diphtheria Efficacy/effectiveness Administration
Rating:
Critically low
2020 ∙ Mahumud, R. A. Alam, K. Keramat, S. A. Ormsby, G. M. Dunn, J. Gow, J.
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Adolescents Adults Human papillomavirus (HPV) Economic aspects
Rating:
Not applicable
Loading...